CTXR logo

CTXR

Citius Pharmaceuticals Inc.

$1.33
-$0.07(-5.00%)
25
Overall
--
Value
25
Tech
26
Quality
Market Cap
$22.46M
Volume
2.36M
52W Range
$0.65 - $15.25
Target Price
$6.00
Order:

Income Statement

MetricTrendChart
2015
Sep
2016
Sep
2017
Sep
2018
Sep
2019
Sep
2020
Sep
2021
Sep
2022
Sep
2023
Sep
2024
Sep
REVENUE
Total Revenue
------$818.3K$90.0K$90.0K$90.0K$90.0K----
Total Revenue
------$818.3K$90.0K$90.0K$90.0K$90.0K----
COST OF GOODS SOLD
Cost of Revenue
----$50.0K$-75.0K------------
GROSS PROFIT
Gross Profit
--$-45.0K$-50.0K$818.3K$90.0K$90.0K$90.0K$90.0K----
OPERATING EXPENSES
Operating Expenses
$3.5M$7.4M$10.0M$13.8M$15.6M$17.7M$23.5M$33.3M$36.7M$42.0M
Research & Development
$1.8M$2.9M$2.9M$6.6M$8.6M$8.8M$12.2M$17.7M$14.8M$11.9M
Research Expense
$1.8M$2.9M$2.9M$6.6M$8.6M$8.8M$12.2M$17.7M$14.8M$11.9M
Selling, General & Administrative
$946.6K$3.8M$6.1M$6.4M$6.3M$8.1M$9.8M$11.8M$15.3M$18.2M
General & Administrative Expenses
$946.6K$3.8M$6.1M$6.4M$6.3M$8.1M$9.8M$11.8M$15.3M$18.2M
Salaries & Wages
$732.2K$732.2K$986.6K$779.7K$716.0K$803.3K$1.5M$3.9M$6.6M$11.8M
Depreciation & Amortization
--$1.3K$2.6K--------------
Depreciation & Amortization
----$2.6K--------------
Amortization
--$1.6M$1.6M$-833.3K--$9.3M--------
Other Operating Expenses
----------$228.8K$239.0K$239.6K$243.6K$17.3M
OPERATING INCOME
Operating income
$-3.5M$-7.4M$-10.0M$-13.0M$-15.6M$-17.7M$-23.5M$-33.3M$-36.7M$-42.0M
EBITDA
$-3.1M$-8.3M$-9.5M$-12.5M$-15.5M$-17.4M$-22.9M$-33.1M$-32.9M$-39.7M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$4.4K$9.0K$850.8K$15.8K$16.4K$15.7K$10.8K------
Intinc
--$806----$52.7K$68.1K$261.8K$251.4K$1.2M$758.0K
Net Non-Operating Interest Income/Expense
$-4.4K$-8.2K$-850.8K$-15.8K$36.2K$52.4K$251.0K$251.4K$1.2M$758.0K
Gain on Sale of Securities
$-332.1K----------$-1.5M------
Other Income/Expense
$-332.1K$838.2K$-452.1K$-450.0K--$-110.2K$1.2M--$-3.6M$-2.4M
Other Special Charges
$768.4K--$1.6M$450.0K--$110.2K$226.5K--$3.6M$2.4M
SPECIAL ITEMS
Restructring And Mn A Income
$6.6M------------------
Special Income Charges
$-6.6M$-11.5M----------------
PRE-TAX INCOME
EBIT
$-3.1M$-8.3M$-9.5M$-12.5M$-15.5M$-17.5M$-23.0M$-33.3M$-33.1M$-39.9M
Pre-Tax Income
$-3.1M$-8.3M$-10.4M$-12.5M$-15.6M$-17.5M$-23.1M$-33.1M$-32.0M$-38.8M
INCOME TAX
Tax Provision
----------$741$1.2K$576.0K$576.0K$576.0K
NET INCOME
Net Income
$-3.1M$-8.3M$-10.4M$-12.5M$-15.6M$-17.5M$-23.1M$-33.6M$-33.7M$-40.2M
Net Income (Continuing Operations)
$-3.1M$-8.3M$-10.4M$-12.5M$-15.6M$-17.5M$-23.1M$-33.6M$-33.7M$-40.5M
Net Income (Discontinued Operations)
$-3.1M$-8.3M$-10.4M$-12.5M$-15.6M$-17.5M$-23.1M$-33.6M$-33.7M$-40.2M
Net Income (Common Stockholders)
$-3.1M$-8.3M$-10.4M$-12.5M$-15.6M$-17.5M$-24.5M$-33.6M$-33.7M$-40.2M
Normalized Income
------------$-18.2M----$-38.5M
TOTALS
Total Expenses
$3.5M$7.4M$10.0M$13.7M$15.6M$17.7M$23.5M$33.3M$36.7M$42.0M
SHARE & EPS DATA
Average Shares Outstanding
$84.9K$144.9K$219.3K$10.7M$806.5K$1.6M$4.3M$5.8M$6.1M$6.7M
Average Shares Outstanding (Diluted)
$84.9K$144.9K$219.3K$10.7M$806.5K$1.6M--$5.8M$6.1M$6.7M
Shares Outstanding
$92.5K$197.6K$336.9K$17.8M$1.2M$2.2M$5.8M$5.8M$6.4M$17.0M
Basic EPS
$-33.75$-56.25$-47.25$-1.17$-19.25$-11.25$-5.75$-5.75$-5.5$-5.97
Basic EPS (Continuing Operations)
$-33.75$-56.25$-47.25$-1.17$-19.25$-11.25$-5.75$-5.75$-5.5$-5.97
Diluted EPS
$-33.75$-56.25$-47.25$-1.17$-19.25$-11.25$-5.75$-5.75$-5.5$-5.97
Diluted EPS (Continuing Operations)
--------------$-5.75$-5.5$-5.97
OTHER METRICS
Accrued Preferred Stock Dividends
------------$1.5M------
Earnings from equity interest
----------$110.2K--------
Earnings From Equity Interest Net Of Tax
----------$110.2K--------
Gain On Sale Of Business
$332.1K------------------
Minority Interests
----------$33.7M$132.8M$103.4M--$287.0K
Net Income Discontinuous Operations
----------------$3.6M$2.4M
Other Gand A
$946.6K$3.8M$6.1M$6.4M$6.3M$8.1M$9.8M$11.8M$15.3M$18.2M
Otherunder Preferred Stock Dividend
------------$1.5M------
Preferred Stock Dividends
------------$1.5M------
Rent And Landing Fees
----$26.0K$6.4M------------
Restruct
$6.6M------------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2CTXR$1.33-5.0%2.36M
3
4
5
6

Get Citius Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.